IP Library Granted Patent US 7,879,591
Granted Patent B2
US 7,879,591 · App. 12/485,141 · Granted Feb 1, 2011

High eicosapentaenoic acid producing strains of

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,591
App. No.
12/485,141
Granted
Feb 1, 2011
Kind
B2
Abstract

Lysophosphatidic acid acyltransferase [“LPAAT”] participates in the second step of oil biosynthesis and is expected to play a key role in altering the quantity of long-chain polyunsaturated fatty acids [“LC-PUFAs”] produced in oils of oleaginous organisms. An LPAAT isolated from Mortierella alpina [“MaLPAAT1”] that is suitable for use in the manufacture of oils enriched in LC-PUFAs in oleaginous organisms is disclosed. Most desirably, the substrate specificity of the instant MaLPAAT1 will be particularly useful to enable increased C 18 to C 20 elongation conversion efficiency and increased Δ4 desaturation conversion efficiency in recombinant host cells producing LC-PUFAs.

Claims (14)

1. An isolated nucleic acid molecule encoding a polypeptide having lysophosphatidic acid acyltransferase activity, selected from the group consisting of:

(a) an isolated nucleic acid molecule encoding the amino acid sequence as set forth in SEQ ID NO:2;

(b) an isolated nucleic acid molecule that hybridizes with (a) under the following hybridization conditions: 0.1×SSC, 0.1% SDS, 65° C. and washed with 2×SSC, 0.1% SDS followed by 0.1×SSC, 0.1% SDS; or,

(c) an isolated nucleic acid molecule that is completely complementary to (a) or (b).

2. The isolated nucleic acid molecule of claim 1 selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:3.

3. An isolated nucleic acid molecule comprising at least one nucleotide sequence selected from the group consisting of:

(a) a nucleotide sequence encoding a lysophosphatidic acid acyltransferase enzyme of at least 314 amino acids that has at least 90% identity based on the BLAST method of alignment when compared to a polypeptide having the sequence as set forth in SEQ ID NO:2; and,

(b) a nucleotide sequence comprising the complement of (a).

4. A recombinant DNA construct comprising the isolated nucleic acid molecule of claim 1 operably linked to at least one regulatory sequence.

5. A transformed host cell comprising the recombinant DNA construct of claim 4 .

6. The transformed host cell of claim 5 , selected from the group consisting of bacteria, yeast, algae, stramenopiles, oomycetes, euglenoids, fungi and plants.

7. The transformed host cell of claim 6 , wherein the yeast is an oleaginous yeast.

8. The transformed host cell of claim 7 , wherein the oleaginous yeast is selected from the group consisting of: Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

9. The transformed host cell of claim 8 , wherein the host cell is Yarrowia lipolytica.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →